A Study of Vyaghryadi Churna (Powder) in the treatment of Tamaka Shwasa (Bronchial Asthma)

Phase 2/3

Not yet recruiting

• Conditions: Other and unspecified asthma. Ayurveda Condition: TAMAKASVASAH,

• Registration Number: CTRI/2021/11/037958
• Lead Sponsor: DR NILAM MAHADEV SAMBRE

Brief Summary

This is a single arm clinical study in which Medicine  Vyaghryadi Churna will be provided to 30 patients showing classical signs and symptoms of Tamaka shwasa (Bronchial Asthma) for relieving symptoms.  The age group taken for the study trial will be between 1years and upto 12 years. Vyaghryadi Churna with Honey will be given on 0th and 7th day for thrice a day .Dose will be calculated by age formula  . Follow-up will be on 7th and 15th day and total duration of the case study will be 15 days.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-09-30
• Study Start: 2022-01-01

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1)CHILDREN WITH SYMPTOMS OF TAMAKA SHWASA AS MENTIONED BY CHARAK ARE AS FOLLOWS SHWASAKRUCHHRATA(DYSPNEA) KASA(COUGH) GHUR GHUR SHABDA(WHEEZING) KASHTEN SHLESHMA MOKSHA(DIFFICULTY IN EXPECTORANT) PEENAS 2)CHILDREN ARE OF AGE GROUP 1YEAR TO 12 YEARS 3)CHILDREN WHO HAVE A HISTORY OF URTI 3-4 TIMES PER YEAR AND ALLERGIC RHINITIS AND ALSO HISTORY OF USING NEBULIZATION FREQUENTLY 4)CHILDREN WILL BE SELECTED IRRESPECTIVE OF SEX SOCIO ECONOMIC STATUS 5)CHILDRENS WHOSE PARENTS ARE READY TO PARTICIPATE IN THE CLINICAL TRIAL BY GIVING INFORM WRITTEN CONSENT.

Exclusion Criteria

1)PATIENTS HAVING LIFE THREATENING ILLNESS AND WHO ARE BED RIDDEN 2)PATIENTS HAVING ANY CONGEITAL RESPIRATORY AND GIT ABNORMALITY 3)PATIENTS WHO REQUIRE SURGICAL MANAGEMENT 4)PATIENTS WITH THE HISTORY OF PULMONARY TUBERCULOSIS PLEURAL EFFUSION EMPHYSEMA BRONCHIAL CARCINOMA STATUS ASTHMATICUS 5)PATIENTS HAVING OTHER SYSTEMIC MAJOR ILLNESS SUCH AS AIDS CARDIAC DISEASE RENAL FAILURE 6)PATIENTS WITH SEVERE ASTHMATICUS CONDITION WHO NEEDS EMERGENCY TREATMENT 7)PATIENTS HAVING DISEASE COVID19 TUBERCULOSIS.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TO EVALUATE THE IMPROVEMENT IN SHWASAKRUCHHRATA AND GHURGHURAK SHABDA AFTER TAKING VYAGHRYADI CHURNA	Vyaghryadi Churna with Honey will be given on 0th and 7th day for thrice a day | Follow-ups will be on 7th and 15th day | Total duration of study will be 15 days

Secondary Outcome Measures

Name	Time	Method
TO STUDY THE CLASSICAL TEXTUAL REVIEW OF TAMAKA SHWASA IN CHILDREN	TO ASSESS THE IMPROVEMENT IN RESPIRATORY RATE ACCORDING TO AGE OF CHILDREN

Trial Locations

Locations (1)

DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE PIMPRI PUNE 18; 🇮🇳 Pune, MAHARASHTRA, India

DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE PIMPRI PUNE 18

🇮🇳Pune, MAHARASHTRA, India

DR NILAM MAHADEV SAMBRE

Principal investigator

8605382856

nilamsambre@gmail.com